影响血清IgG亚类水平调节的序列变异
Thorunn A Olafsdottir1,2, Gudmar Thorleifsson3, Aitzkoa Lopez de Lapuente Portilla4,5
1deCODE genetics/Amgen Inc., Reykjavik, Iceland. thorunno@decode.is.
Nature communications
|September 14, 2024
概括
全基因组关联研究揭示了影响免疫球蛋白G (IgG) 亚类水平的新遗传变异. 这些发现提供了关于抗体介导免疫和疾病风险的见解,可能有助于治疗的发展.
科学领域:
- 免疫遗传学 免疫遗传学
- 人类免疫学 人类免疫学
- 遗传流行病学遗传流行病学
背景情况:
- 免疫球蛋白G (IgG) 是人体循环中的主要抗体同型,有四个子类 (IgG1-IgG4).
- 对IgG亚类的恒定区域基因位于Ig重链局部 (IGH).
- 了解IgG亚类水平的遗传调节对于免疫系统研究至关重要.
研究的目的:
- 进行全基因组关联研究 (GWAS),以确定影响人类IgG亚类水平的遗传变异.
- 探索这些变体与免疫相关疾病和血液特征的关联.
- 研究抗体介导免疫的调节机制.
主要方法:
- 全基因组关联研究 (GWAS) 对4334名成年人和4571名18岁以下的个人进行.
- 在五个影响IgG亚类水平的基因位置上分析了十种新的和四种已知的遗传变异.
- 检查遗传变异,IgG子类水平和疾病风险 (喘,自身免疫性疾病) 之间的关联.
主要成果:
- 在五个位置发现了10种新型和四种先前确定的影响IgG亚类水平的遗传变异.
- 七个变异被映射到IGH位点,三个到Fcγ受体 (FCGR) 位点,两个到人类白细胞抗原 (HLA) 区域.
- 在特定的全型 (G1m(f),G2m(n),G3m(b*)) 和IgG1,IgG2和IgG3水平之间发现了显著的关联.
- 在16p11.2 (ITGAX) 和17q21.1 (IKZF3,ZPBP2,GSDMB,ORMDL3) 观察到与IgG4的选择性关联.
- 在17q21.1处的类信号显示了一种与较低IgG4水平相关的等位基因,可以防止儿童喘,但增加炎症性肠道疾病的风险.
结论:
- 在IGH,FCGR和HLA区域的遗传变异显著影响IgG亚类水平.
- 特定的基因位置与IgG4水平相关,并对免疫相关疾病表现出性作用.
- 这些发现增强了我们对抗体介导免疫调节的理解,并可能为基于抗体的治疗方法的开发提供信息.
相关概念视频
01:10Antibody Structure
59.6K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
59.6K
01:15Transcytosis of IgG
2.7K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
2.7K
01:25Antibody Structure and Classes
852
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
852
01:36Humoral Immune Responses
72.2K
Overview
72.2K
01:29Factors Affecting Protein-Drug Binding: Patient-Related Factors
45
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
45